Skip to main content

Table 4 Antihistamine Utilization (Entire Observation Period) - Stratified by Provider Type

From: Effects of variations in access to care for children with atopic dermatitis

 

Dermatologist

A/I

Pediatrics

Other

Number of patients, n (%)

58,758 (12.3)

29,994 (6.3)

169,455 (35.5)

219,277 (45.8)

Systemic antihistamine use, n (%)

17,195 (29.3)

13,146 (43.8)

63,904 (37.7)

128,083 (58.4)

 Non-sedating antihistamine onlya, n (%)

4651 (27.0)

6556 (49.9)

32,424 (50.7)

63,284 (49.4)

  ≥1 sedating antihistamine, n (%)

12,544 (72.9)

6590 (50.1)

31,480 (49.3)

64,799 (50.6)

Medicaid-insured patients, n (%)

8160

7144

60,268

165,076

Systemic antihistamine use, n (%)

5933 (72.7)

6123 (85.7)

42,416 (70.4)

116,039 (70.3)

 Non-sedating antihistamine onlya, n (%)

2467 (41.6)

3897 (63.6)

25,852 (60.9)

59,976 (51.7)

  ≥1 sedating antihistamine, n (%)

3466 (58.4)

2226 (36.4)

16,564 (39,1)

56,063 (48.3)

Commercially insured patients, n (%)

50,598

22,850

109,187

54,201

Systemic antihistamine use, n (%)

11,262 (22.3)

7023 (30.7)

21,488 (19.7)

12,044 (22.2)

 Non-sedating antihistamine onlya, n (%)

2184 (19.4)

2659 (37.9)

6572 (30.6)

3308 (27.5)

  ≥1 sedating antihistamine, n (%)

9078 (80.6)

4364 (62.1)

14,916 (69.4)

8736 (72.5)

  1. A/I Allergist/Immunologist, Rx Prescription
  2. aNon-sedating antihistamines do not require Rx, but some Medicaid plans will cover the cost with Rx